Showing 5751-5760 of 6035 results for "".
- Joe Garibaldi Appointed Vice President of US Sales at Optovuehttps://modernod.com/news/joe-garibaldi-appointed-vice-president-of-us-sales-at-optovue/2476172/Joe Garibaldi has been appointed to vice president of US Sales at Optovue, where he will continue to lead the US sales force as well as identify new strategic partnering opportunities to grow the company’s US product portfolio. Garibaldi joined Optovue in 2009 as a territory manager and he
- Lifestyle Choices May Help Glaucoma Patients Preserve Eyesighthttps://modernod.com/news/lifestyle-choices-may-help-glaucoma-patients-preserve-eyesight/2476174/Glaucoma is one of the leading causes of vision loss, aff
- Compulink Showcases SMART Ophthalmology EHR Solution at Hawaiian Eye 2019https://modernod.com/news/compulink-showcases-smart-ophthalmology-ehr-solution-at-hawaiian-eye-2019/2476177/Compulink Healthcare Solutions will demonstrate its ophthalmology-specific system, Ophthalmology Advantage at Hawaiian Eye. Ophthalmology Advantage uses AI technology and real-time data from the clinic to completely automate tasks such as billing, along with eliminating steps to improve pa
- DORC Unveils Enhancements to the EVA Phacovitrectomy Systemhttps://modernod.com/news/dorc-unveils-enhancements-to-the-eva-phacovitrectomy-system/2476178/DORC has announced the launch several enhancements to its EVA surgical system aimed at delivering both operating room efficiency and surgical performance. The enhancements include a new EVA footswitch that been completely redesigned. Control of the EVA endolaser is now integrated into the
- Burnout Rises Above 50% in Some Specialties, New Survey Showshttps://modernod.com/news/burnout-rises-above-50-in-some-specialties-new-survey-shows/2476179/Responses to a new Medscape survey indicate that 44% of physicians meet the criteria for burnout, up from 42% in last year’s report. In addition, 11% are colloquially depressed (feeling down or sad), and 4% are clinically depressed, according to the
- Cyclosporine Emulsion Promising in Vernal Keratoconjunctivitishttps://modernod.com/news/cyclosporine-emulsion-promising-in-vernal-keratoconjunctivitis/2476182/Cyclosporine A cationic emulsion (CsA CE) appears more effective than vehicle alone in treating pediatric patients with vernal keratoconjunctivitis, according to a study funded by the developer, Santen, as reported by Reuters. In a
- MANF Therapeutics Receives Notice of Allowance from US Patent & Trademark Office Covering the Use of MANF or CDNF for Ophthalmic Diseaseshttps://modernod.com/news/manf-therapeutics-receives-notice-of-allowance-from-us-patent-trademark-office-covering-the-use-of-manf-or-cdnf-for-ophthalmic-diseases/2476184/MANF Therapeutics, a wholly-owned subsidiary of Amarantus Bioscience Holdings, is in preclinical development advancing mesencephalic astrocyte-derived neurotrophic factor (MANF) as a disease-modifying treatment for orphan ophthalmological conditions and neurodegenerative diseases. On Tuesday, the
- FDA to Boost Staff to Help Handle Anticipated Increase in Cell and Gene Therapy Filingshttps://modernod.com/news/fda-to-boost-staff-to-help-handle-anticipated-increase-in-cell-and-gene-therapy-filings/2476185/FDA Commissioner Scott Gottlieb said Tuesday that the agency’s “eventual goal” is to add about 50 additional clinical reviewers to the group that oversees the clinical investigation, development, and review of cell and gene therapy products. He also cited the more than 800 activ
- US House Oversight Committee Launches Investigation into Prescription Drug Pricinghttps://modernod.com/news/us-house-oversight-committee-launches-investigation-into-prescription-drug-pricing/2476191/The US House of Representatives’ Oversight Committee on Monday announced a probe into a dozen pharmaceutical companies regarding drug pricing. In the investigation, Representative and committee chairman Elijah Cummings sent letters to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson
- Take Diabetes Into Consideration When Assessing for Glaucomahttps://modernod.com/news/take-diabetes-into-consideration-when-assessing-for-glaucoma/2476193/Diabetes and hyperglycemia are associated with thicker central corneal thickness (CCT), which could lead to overestimation of intraocular pressure when assessing patients for glaucoma, new research suggests, as reported by Medscape.